It has been a global query; will allergies caused by peanuts become just a part of the history?

Scientists and experts have already discovered a method to stop the life-threatening allergic reactions caused by foods like peanuts. That was done by playing some kind of a trap in the immune system.

The Northwestern University Feinberg School of Medicine’s assistant professor of medicine, Dr. Paul J. Bryce explained in his written statement that he and his colleagues think that they have already discovered a method in order to securely and quickly turn off or stop the allergic response, especially to allergies caused by foods such as peanuts.

The research was further explained in the Journal of Immunology, in which a study was conducted through experiments on specially bred mice to be in a situation that copies food allergies that are really serious. The scientists connected proteins from peanuts to the blood cells (leukocytes) and introduced them again into the bodies of the mice. They observed the moment the mice ate the peanut extract and saw no allergic reaction to the mice.

Moreover, Dr. Bryce further noted that the mice’s immune system saw the proteins from peanuts as completely ordinary, since it was already showed in the white blood cells. Additionally, without the help of the treatment, those experimented animals would have gone through an anaphylactic shock.

Anaphylactic shock or also known as anaphylaxis is characterized as an allergic reaction in the whole body marked by a list of indications such as cough, abdominal pain, nausea, difficulty in breathing and swallowing, vomiting, anxiety, and nasal congestion.

Related Posts:

• HIV Controllers May Restrict Full Blown AIDS
• Coffee Can Heighten Your Resistance

Tuberculosis is recognized as the second largest infectious killer in the history of the world.

But today, the figures present that new cases of the disease is now dropping annually for the very first time within a timeframe of twenty years or two decades. This is a long-sought turning point for the disease.

Tuberculosis is characterized as an infection in the lungs that can multiply to any other organ virtually. The disease has already affected a lot of individuals for more than 15,000 years. In the past year, TB has killed about 1.4 million individuals globally.

The disease has been long associated with poverty. However, the spread of the disease seem to have the unanticipated development in the past 25 years with the existence of AIDS. Among all the infectious disease, AIDS took on the larger charge.

Individuals who are infected with HIV are said to probably develop tuberculosis thirty times compared to those individuals who do not have AIDS. The records tell that a quarter of the people who died from TB in the past year also had with them the virus causing AIDS.

The epidemiologists from World Health Organization had announced in Tuesday that the fall down of new cases of TB had started late in 2006, however, it was only known until this year, when the updated data from India, China and some other seventeen African countries became available. With that, they had revised the estimations of global cases of TB and entirely the overall trend of the disease.

Related Posts:

• No Related Posts

The month of October is globally recognized as the Month for Breast Cancer Awareness. The pink ribbon has become the symbol of such event and has been seen everywhere.

The need for having additional research and treatment for breast cancer is becoming more pressing compared to the earlier years. However, the campaigns of corporate pink ribbon have been so ordinary that such need appeared to be not that authentic anymore.

In addition, several of the campaigns were considered as not an appropriate act of fighting against breast cancer. Such examples of breast cancer initiatives that were out of place are pink toilet paper, pink candy, and the likes. Some movements were actually identified as dangerous.

According to Breast Cancer Action, an advocacy group for fighting against breast cancer, the new battle against breast cancer today is called “Pinkwashing.” This is a perfume named “Promise Me” specially made by Susan Komen for the Cure. The perfume includes ingredients that were not listed as hazardous and toxic.

The support being given to the breast cancer movements by some corporations is now required to move from just being an October marketing tactic to an authentic, long-term obligation to an important matter that is extremely significant among women.

Corporations, in order to embody and express their social purpose around them, must make women’s health issues such as breast cancer a high priority.

A very good example of this is Shoppers Drug Mart. They have been very sensitive when it comes to the health issues and problems among women. According to the company, women’s health problems and issues are ought to be given importance and attention, because women play a big role in the growth and success of companies such as Shoppers Drug Mart.

Related Posts:

• No Related Posts

The pharma giant Roche has already took its very first step clinically in a very long adventure, which the company expects would direct them to a market that will make them a mega-blockbuster hit.

Roche stated that their process of a small, early-stage study of formulating the treatment for Alzheimer’s disease called gantenerumab had worked as what they have been praying to happen.

For today, the researchers will be setting out in order to distinguish if they are still on the right path.

The researchers have reported that the new treatment generated an important fall in amyloid plaque, at the same time as the similar biomarker suspect for Alzheimer’s remained to build up in the placebo arm. This is during the experimentation of two doses of gantenerumab among the sixteen patients within six months timeframe.

In addition, experts also affirmed the effects it will cause on the amyloid plaque in an ex vivo lab test with the use of the samples given from the patients’ tissues.

The global neuroscience disease division head of Roche, Ms. Luca Santarelli explained that the results they have, especially the quickness of the effects examined on the removal of amyloid are very much encouraging. It will also pave the way for the enhancement of a new treatment for the disease.

The medicine formulated is recognized as an antibody, proving its capacity to break through the complex blood-brain barrier.

Related Posts:

• No Related Posts

The University of Wisconsin-Madison’s researchers, which included one with an Indian-origin, have already distinguished a particular gene that could help explain the reasons on why some individuals are more vulnerable to diabetes.

The gene is said to be found on the experiments they had on mice which are obese. They found that the gene can manipulate tomosyn-2 and actually acts as a brake on the secretion of insulin from the pancreas.

Mr. Alan Attie, the lead researcher of the study, explained that it is still too early for him and his colleagues to identify the relevance of the said gene to the diabetes experienced by human beings. However, the idea of a negative regulation is one of the most fascinating things that came out of their study and is very much applicable to human studies.

While looking for genes that could contribute to the vulnerability of diabetes in obese mice, the researchers have found tomosyn-2.

Comparisons and analyses of genetics of obese mice strains from those which are vulnerable and resistant to diabetes showed that a single amino acid differentiation weakens off the tomosyn-2 protein in mice that are resistant to diabetes. This efficiently releases the brake on the secretion of insulin from the pancreas, which permits the animals to discharge adequate insulin to prevent diabetes.

Additionally, even though the disease is highly not to be caused by a single gene, by distinguishing significant genetic passageways that can recommend useful targets clinically.

The researchers concluded that their study presented the power of genetics in discovering new methods for intricate diseases such as type 2 diabetes.

Related Posts:

• Stem Cells Provide Potential in Treating Diabetes
• Low Fat Diet Wards Off Diabetes Risk
• Artificial Pancreas for Pregnant Women Acts as a Lifesaver
• Artificial pancreas can change the lives of diabetic patients
• Medicare Could Save Money from Weight Loss Programs

According to the CDC or the Centers for Disease Control and Prevention, there is now a total of twenty-one individuals all over the country have now died in the outbreak of listeriosis associated with cantaloupes, which came from the farms of Colorado.

The CDC further stated that all in all, all over the 23 states, there are already 109 individuals who have become sick due to the reported outbreak, and the figures could increase if the outbreak still remains.

The report also presented the updated version of their list: Indiana, the newest, where one pregnant woman had a miscarriage at the time she had the illness; one person dead each in Maryland, New York, Oklahoma, Missouri, Wyoming and Nebraska; two in Texas and Kansas; and five deaths in New Mexico and Colorado.

Moreover, the CDC reported that the listeriosis outbreak is now recognized as one of the deadliest illnesses in U.S. Records showed that in 1985, there was a Mexican-style soft cheese contaminated with listeria, which came from Jalisco Products. It had killed ten newborns and eighteen adults, also causing twenty miscarriages and sickened around 142 other people.

CDC, along with the Food and Drug Administration, said that any cantaloupes that did not come from Jensen Farms are safe to take in. The outbreak was actually connected with the cantaloupes from Jensen Farms, specifically the Rocky Ford-brand cantaloupes. The products were recalled last September 14, and most of the contaminated ones should be out of the food supply by now.

Related Posts:

• Outbreak of Listeria from Cantaloupes Poses Risks to Several States
• Mexican Papayas May be Banned Entry to the U.S.
• US Food Safety System Overhauled by Senate
• Cultural Change Sought in FDA
• Drugs for Osteoporosis Gets FDA Review

According to the FDA’s advisers, drug makers for osteoporosis are now required to explain the period on which the patients must take in famous treatments so that to avoid side effects that is harmful.

Those drugs are recognized as biphosphonates, which included best selling brands such as Boniva, Atelvia, Actonel, Reclast and Osamax. The Food and Drug Administration will be determining later on whether those brands will be required to affirm the period on how long the patients must take in every drug. However, it is still not clear how long that might take.

FDA reports that last 2009, there were over five million prescriptions that were filled up for biphosphonates alone, wherein it can reverse dangerous thinning of bones, and prevent spine and hip fractures that cause pain which results severe problems in health.

There were a few studies that were reviewed by the panel of advisers to the FDA last Friday. From their reviews, they have found out that there were some patients who had suffered severe complications, which included unusual thighbone fractures, jawbone damage, and esophagus cancer following some years of taking in those treatments. Some patients have taken legal action and sued the makers of the recognized drugs.

The previous president of the American Society for Bone and Mineral Research, Dr. Elizabeth Shane stated that the side effects are just like atypical fractures and osteonecrosis of the jaw are identified as extremely rare especially when viewed in the concept of the quantity of people who took such drugs for osteoporosis.

Related Posts:

• Prolia as Osteoporosis Treatment for Post-Menopausal Women
• Sutent Receives FDA Consent as Pancreatic Cancer Cure
• Novartis Drug Draws Hope for Rare Pancreatic Cancer
• Listeriosis Outbreak Claims 21 Lives – Now At Its Deadliest
• Firazyr Approved by FDA for Angioedema Treatment

Health officials from Colorado announced that there was an investigation that came into the outbreak of listeria, which has killed not more than one individual, and has developed including three states wherein it could probably contaminated cantaloupe was consumed.

In a report released by the Colorado Department of Public Health and Environment, out of the nine affirmed cases in Colorado on gastrointestinal infection, there was one supposed case in Nebraska and there were two supposed cases in Texas, and all of those patients were found to have lately eaten cantaloupe.

The department’s chief medical officer, Chris Urbina, declared that the officials have not yet outlined where the contaminated cantaloupes were sold and bought.

Moreover, Urbina noted that it is sensible for individuals who are at high risk for the infection of listeria in preventing cantaloupe consumption, while the investigation on the outbreak of listeria’s source is still continuing.

He added that those individuals who were most likely to be infected by the bacteria included people who are aged 60 years and above, people whose immune systems have been deteriorated with such organ transplants or diseases, and also pregnant women.

The infection is now spreading to several states in the United States, and because of that, the investigation is now coordinated by the US Centers for Disease Control and Prevention together with the US Department of Agriculture and FDA.

Related Posts:

• Listeriosis Outbreak Claims 21 Lives – Now At Its Deadliest

According to the new government data presented, there is about half of the US population who drink beverages that are sugar-sweetened on any time of the day, having young men and teens taking in more than the suggested limitations for staying healthy.

The results were from the Centers for Disease Control and Prevention. It showed the figure on which the consumer’s habits are needed to be changed in order to help fight against the obesity epidemic of the country. There are almost two-thirds of the populations of American people if they are obese or overweight.

Los Angeles, Philadelphia, Seattle, Boston, and San Antonio city health departments have declared new proposals for a new and fresh promotion in encouraging people to cut down on their consumption of sugary beverage, which is coinciding with the data presented by CDC.

The executive director of CSPI or Center for Science in the Public Interest, Michael Jacobson stated that they are much concerned about the sugary beverages since these are the only factors that are connected directly with obesity. The reduction in people’s consumption is the perfect strategy in reducing the obesity epidemic.

Together with the American Diabetes Association and the American Heart Association, CSPI is working with a new promotion along with the officials of the city.

For the CDC’s research, they have interviewed about 17,000 American people about their diets. The results show that the typical female is consuming94 calories from sugary beverages, while the average male is consuming 175 calories in just one day from such drinks.

Cynthia Ogden, the author of the study confirmed that this is one aspect wherein individuals can observe if they are trying to regulate the sugary consumption they have now.

Related Posts:

• Diabetes Time Bomb in America is Ticking
• Study Seeks to Explain Gene Linked to Diabetes Vulnerability
• Listeriosis Outbreak Claims 21 Lives – Now At Its Deadliest
• Chocolates Lessen Risk of Heart Diseases
• University of Tennessee Nutrition Program to Cut Off Jobs

Icatibant subcutaneous injection or Firazyr has been approved by the U.S. Food and Drug Administration (FDA) as a treatment of HAE or hereditary angioedema’s acute attacks, especially in people aging eighteen years or above.

The treatment is a bradykinin B2 receptor antagonist and is offered in a pre-filled syringe, which can be kept inside rooms having the regular room temperature up til 77 degrees Fahrenheit for immediate use and portability.

According to the director of the Office of Drug Evaluation II in the Center for Drug Evaluation and Research in FDA, Curtis Rosebraugh, MD, MPH, Firazyr is providing a fresh new choice in treating HAE’s acute attacks; and since it can be done by oneself by means of an injection in the abdominal area. Additionally, the patients can immediately treat themselves seeing that they are experiencing the attack of HAE.

The approval was rooted from the records coming from three double-blind controlled and randomized clinical trials, with a total number of 223 participants. This showed a dosage of thirty milligrams of Icatibant appreciably lessened the mean time in symptom relief, which is in relation with placebo.

The results of the research were substantiated by a thorough analysis of data from the chosen clinical trials. The patients who took Icatibant have gone through a reduction of fifty percent from the basic symptoms during the mean time of 2 to 2.3 hours. The gap did not differ when the treatment was repeated for the first five attacks of HAE. Majority of the patients were resolved with just a single dosage came up with 93 percent. The effectiveness also did not differ regarding nonlaryngeal versus laryngeal sites of attack, nor with the clinician administration of medication versus patient.

Related Posts:

• Listeriosis Outbreak Claims 21 Lives – Now At Its Deadliest
• Drugs for Osteoporosis Gets FDA Review
• Who is More Susceptible to Amgen’s New Bone Drug?
• Prolia as Osteoporosis Treatment for Post-Menopausal Women